Pure Global

AGAPPE HbA1C Mispa i3 - Indonesia BPOM Medical Device Registration

AGAPPE HbA1C Mispa i3 is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20207715970. The device is manufactured by AGAPPE DIAGNOSTICS SWITZERLAND GMBH from Switzerland, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. MULTIMEDILAB KARYAMANDIRI.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
AGAPPE HbA1C Mispa i3
Analysis ID: AKL 20207715970

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

Switzerland

Authorized Representative

PT. MULTIMEDILAB KARYAMANDIRI

AR Address

GP plaza lantai 3 unit 6, jalan Gelora II No. 01

Registration Date

May 31, 2022

Expiry Date

Feb 07, 2027

Product Type

Haematology Package and Kit

Glycosylated hemoglobin assay.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Other Products from AGAPPE DIAGNOSTICS SWITZERLAND GMBH
Products from the same manufacturer (2 products)